Skip to main content
. 2020 Feb 3;111(3):817–825. doi: 10.1111/cas.14302

Table 1.

Correlation between mast cells infiltration and patient characteristics

Characteristic Patients (n = 289) TIM infiltration P a
Number % Low (n = 145) High (n = 144)
Age at surgery, yearsb
Mean ± SD 63.09 ± 11.06 61.68 ± 11.19 64.50 ± 10.77 0.031
Gender
Female 185 64.0 92 93 0.84
Male 104 36.0 53 51  
pT‐stage
T2 171 59.2 87 84 0.81
T3 85 29.4 40 45  
T4 33 11.4 18 15  
pN‐stage
N0 226 78.2 113 113 0.837
N1 53 18.3 26 27  
N2 10 3.5 6 4  
TNM stage
II 159 55.0 80 79 0.537
III 79 27.3 35 44  
IV 51 17.7 30 21  
Tumor differentiation
Well, moderate 154 53.3 72 82 0.304
Poor 135 46.7 73 42  
Residual tumor
R0 255 88.2 131 124 0.266
R1 34 11.8 14 20  
Vascular invasion
Absent 196 67.8 101 95 0.504
Present 93 32.2 44 49  
ACT
Absent 179 61.9 93 86 0.441
Present 110 38.1 52 58  

ACT, adjuvant chemotherapy; TIM, tumor‐infiltrating mast cells; SD, standard deviation.

a

P < 0.05 is considered statistically significant.

b

The results of continuous variables are presented as mean ± SD.

Bold value is considered statistically significant.